Andreas Wenger
Overview
Explore the profile of Andreas Wenger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
370
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kiselev N, Amsler S, Boumparis N, Dey M, Wenger A, Schnoz D, et al.
Swiss Med Wkly
. 2024 Oct;
154:3895.
PMID: 39463329
Background: Recent trends in Switzerland indicate a concerning rise in simultaneous polysubstance use among adolescents, a practice marked by the concurrent or sequential consumption of multiple psychoactive substances, notably alcohol...
2.
Josuran R, Wenger A, Muller C, Kampa B, Worbs S, Dorner B, et al.
Toxins (Basel)
. 2024 Jun;
16(6).
PMID: 38922138
A certified reference material of ricin (CRM-LS-1) was produced by the EuroBioTox consortium to standardise the analysis of this biotoxin. This study established the -glycan structures and proportions including their...
3.
Boumparis N, Baumgartner C, Malischnig D, Wenger A, Achab S, Khazaal Y, et al.
J Behav Addict
. 2023 Sep;
12(3):744-757.
PMID: 37659086
Background And Aims: Problem gambling constitutes a public health concern associated with psychopathological comorbidity, substance use, and financial difficulties. Most individuals with gambling problems avoid counseling services due to perceived...
4.
Haug S, Boumparis N, Wenger A, Schaub M, Kiselev N
Int J Environ Res Public Health
. 2023 Jul;
20(14).
PMID: 37510611
Background: Digital interventions are an emerging and promising avenue for addiction prevention and mental health promotion, but their reach and use are often limited, and little is known about the...
5.
Boumparis N, Noroozi A, Naghizadeh E, Meyer A, Wenger A, Rahimi-Movaghar A, et al.
BMC Psychiatry
. 2023 Jul;
23(1):518.
PMID: 37464337
Background: The pattern of substance use in Iran is characterized by a high prevalence of opioid use and opioid use disorder (OUD). Although opioid maintenance therapy (OMT) has been introduced...
6.
Haug S, Boumparis N, Wenger A, Paz Castro R, Schaub M
Int J Environ Res Public Health
. 2023 Feb;
20(4).
PMID: 36833958
Background: At-risk alcohol use, particularly binge drinking, is widespread among adolescents and young adults in most Western countries. is a mobile app-based program for alcohol prevention that provides individualized coaching...
7.
Haug S, Boumparis N, Wenger A, Schaub M, Paz Castro R
Int J Environ Res Public Health
. 2022 Dec;
19(23).
PMID: 36497804
Background: Addictive behaviors such as tobacco/e-cigarette smoking, at-risk alcohol consumption, cannabis use or compulsive internet use are common among apprentices. is a mobile app-based preventive intervention program for apprentices that...
8.
Paz Castro R, Haug S, Wenger A, Schaub M
Am J Prev Med
. 2022 Aug;
63(6):944-953.
PMID: 35985899
Introduction: The main objective of this study was to test the longer-term and differential efficacy of a mobile phone‒based life-skills training program designed to prevent substance use among adolescents. Study...
9.
Frohlich J, Rapinda K, Schaub M, Wenger A, Baumgartner C, Johnson E, et al.
Addict Behav Rep
. 2022 Jun;
16:100437.
PMID: 35694108
Given prevalent alcohol misuse-emotional comorbidities among young adults, we developed an internet-based integrated treatment called . Although the treatment had an impact on several secondary outcomes, effects were not observed...
10.
Ahlers J, Baumgartner C, Augsburger M, Wenger A, Malischnig D, Boumparis N, et al.
J Med Internet Res
. 2022 Apr;
24(4):e30138.
PMID: 35442196
Background: Prevalence rates for lifetime cannabis use and cannabis use disorder are much higher in people with attention deficit/hyperactivity disorder than in those without. CANreduce 2.0 is an intervention that...